CIK 0001175151 · Non-accelerated filer<br>Smaller reporting company
Cytosorbents Corp
Sign in to watch- Ticker
- CTSO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980373793
- Phone
- 973-329-8885
- Business address
- 305 COLLEGE ROAD EAST, PRINCETON, NJ, 08540
- Former names
- MedaSorb Technologies CORP, GILDER ENTERPRISES INC
- 8-K Event Other events
- 4 Option exercise President and CEO acquired 8,000 shares (option exercise)
- 8-K Event Other events
- 8-K Event Shareholder vote results
- 8-K Event Other events
- 424B5 Offering Prospectus
- 4 Open-market sale Chief Operating Officer sold 28,000 shares at $10.00 ($280,000)
- 4 Open-market sale Chief Operating Officer sold 4,846 shares at $9.00 ($43,614)
- 4 Open-market sale Chief Operating Officer sold 7,154 shares at $9.00 ($64,386)
- 4 Open-market sale Chief Financial Officer sold 12,400 shares at $9.00 ($111,600)
- 4 Open-market sale Chief Financial Officer sold 12,400 shares at $8.75 ($108,500)
- 4 Open-market sale Chief Financial Officer sold 10,000 shares at $8.50 ($85,000)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Grant or award Director acquired 3,300 shares (grant or award)
- 4 Grant or award Director acquired 3,300 shares (grant or award)
- 4 Grant or award Director acquired 3,300 shares (grant or award)
- 4 Grant or award Director acquired 3,300 shares (grant or award)
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
Page 23 of 49 · 978 filings